• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Tobacco Products

  • Print
  • Share
  • E-mail
  • en Español en Español

Public Health Advocates Stakeholder Discussion Series Session

The U.S. Food and Drug Administration (FDA) Center for Tobacco Products (CTP) held its fourth Stakeholder Discussion Series session with Public Health Advocates from 9:00 am to 5:30 pm on Thursday, June 9, 2011 at the:

Center for Tobacco Products
9200 Corporate Blvd.
Rockville, MD 20815
Room 020 B

The U.S. Food and Drug Administration (FDA) Center for Tobacco Products (CTP) is charged with implementing the Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act) with the goal of reducing the tremendous toll of disease and death caused by tobacco product use.

In order to better ensure the opportunity for meaningful engagement and dialogue between CTP and public health advocates, a limited number of individuals have been invited to actively participate in the discussion. This approach is based on feedback we have received from stakeholder input on the design of these sessions. Approximately 30 members of the public -- or additional representatives of the public health community participating in the meeting -- may observe the general sessions held in the main room at the meeting site.  

Stakeholder Discussion Series Session Materials

Meeting Presentations

View the Stakeholder Discussion Series Sessions Schedule

If you need assistance to access these documents, please email the FDA Center For Tobacco Products.